V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212637 | 20079235 | 1.56 | 61 | Neo-adjuvant (N) | 2020-01-22 | 2020-01-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101510123 |
| 20212638 | 20079236 | 1.76 | 90.7 | Palliative (P) | 2020-03-13 | 2020-03-21 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101531523 |
| 20212639 | 20079237 | 1.69 | 85 | Palliative (P) | 2018-02-28 | 2018-03-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100201549 |
| 20212640 | 20079238 | 1.58 | 50.5 | Palliative (P) | 2017-03-02 | 2017-03-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101570229 |
| 20212643 | 20079239 | 1.54 | 89.7 | Palliative (P) | 2019-06-18 | 2019-06-28 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100372930 |
| 20212644 | 20079240 | 1.6 | 59 | Palliative (P) | 2018-09-08 | 2018-09-08 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100189452 |
| 20212645 | 20079241 | 1.75 | 83.2 | Neo-adjuvant (N) | 2017-08-22 | 2017-09-05 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101256391 |
| 20212646 | 20079242 | 1.9 | 78.9 | Palliative (P) | 2018-06-01 | 2018-06-09 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100359117 |
| 20212647 | 20079243 | 1.65 | 68.3 | null | 2018-06-24 | 2018-07-09 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100109895 |
| 20212648 | 20079244 | 1.5 | 49.4 | Palliative (P) | 2018-08-22 | 2018-08-31 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100266495 |
| 20212649 | 20079245 | 1.65 | 111.1 | 03 | 2020-02-15 | 2020-02-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101126828 |
| 20212650 | 20079246 | 0 | 0 | Curative (C) | 2017-03-29 | 2017-04-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100450023 |
| 20212651 | 20079247 | 1.66 | 89 | null | 2020-06-23 | 2020-07-02 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101281902 |
| 20212652 | 20079248 | 1.8 | 65 | Neo-adjuvant (N) | 2016-08-20 | 2016-09-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100910148 |
| 20212654 | 20079249 | 1.58 | null | Neo-adjuvant (N) | 2018-08-04 | 2018-08-20 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101830278 |
| 20212655 | 20079250 | 1.54 | 60 | Adjuvant (A) | null | 2016-10-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101219392 |
| 20212656 | 20079251 | 1.8 | 63.5 | Neo-adjuvant (N) | 2016-07-23 | 2016-07-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101853698 |
| 20212658 | 20079252 | 1.73 | 71.2 | Palliative (P) | 2018-03-13 | 2018-03-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100480130 |
| 20212659 | 20079253 | 1.69 | 62.8 | null | 2022-05-04 | 2022-05-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101239880 |
| 20212660 | 20079254 | null | null | Curative (C) | null | 2018-04-05 | Doxorubicin chemoembolisation | null | Y | DOXORUBICIN EMBOLISATION | 100530904 |
| 20212661 | 20079255 | 1.62 | 76 | Curative (C) | 2018-03-12 | 2018-03-15 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101790355 |
| 20212662 | 20079256 | 1.69 | 64.35 | Curative (C) | 2016-09-28 | 2016-10-19 | Capecitabine (14 days)+Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100697243 |
| 20212663 | 20079257 | 1.55 | 75.8 | Palliative (P) | 2017-07-28 | 2017-08-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100762404 |
| 20212664 | 20079258 | 1.76 | 84.3 | Curative (C) | 2017-03-03 | 2017-03-05 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100397732 |
| 20212667 | 20079259 | 1.7 | 99 | Neo-adjuvant (N) | 2018-10-17 | 2018-10-17 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 100268146 |
| 20212668 | 20079260 | 1.52 | 124.4 | Curative (C) | 2016-08-09 | 2016-08-09 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100522124 |
| 20212669 | 20079261 | 0 | 0 | Neo-adjuvant (N) | 2017-09-29 | 2017-10-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100604356 |
| 20212670 | 20079262 | 1.67 | 67 | Palliative (P) | 2019-12-05 | 2019-12-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100828905 |
| 20212671 | 20079263 | 1.79 | 79.6 | Curative (C) | 2016-10-28 | 2016-10-28 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 100765858 |
| 20212674 | 20079264 | 1.72 | 71.6 | Palliative (P) | 2017-04-07 | 2017-04-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101528707 |
| 20212675 | 20079265 | 1.72 | 87.5 | Neo-adjuvant (N) | 2018-01-10 | 2018-02-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101167549 |
| 20212676 | 20079266 | 1.77 | 110.9 | Palliative (P) | null | 2016-06-03 | CAPECITABINE + CARBOPLATIN | 02 | Y | TRIAL UNSPECIFIED | 100851515 |
| 20212677 | 20079267 | 1.6 | 58.6 | Palliative (P) | 2018-08-16 | 2018-08-22 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101431171 |
| 20212678 | 20079268 | 1.69 | 77.8 | Neo-adjuvant (N) | 2017-06-30 | 2017-06-30 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100985769 |
| 20212679 | 20079269 | null | 93.3 | Palliative (P) | null | 2018-02-19 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101681074 |
| 20212680 | 20079270 | 1.7 | 103.7 | Curative (C) | 2017-02-23 | 2017-03-09 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100530215 |
| 20212682 | 20079271 | 1.76 | 93.8 | Curative (C) | 2019-06-02 | 2019-06-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100753671 |
| 20212684 | 20079272 | 1.91 | 94.8 | Curative (C) | 2017-10-16 | 2017-10-23 | Capecitabine (21days) + Carboplatin | 2 | Y | CAPECITABINE + CARBOPLATIN | 101322392 |
| 20212686 | 20079273 | null | 101 | Palliative (P) | 2019-07-16 | 2019-08-25 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100703952 |
| 20212687 | 20079274 | 1.62 | 49.2 | Palliative (P) | 2019-09-21 | 2019-10-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101372772 |
| 20212688 | 20079275 | 1.64 | 62.3 | Neo-adjuvant (N) | 2016-07-22 | 2016-07-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100735532 |
| 20212689 | 20079276 | 1.7 | 75.6 | 03 | 2020-01-06 | 2020-01-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101154575 |
| 20212690 | 20079277 | 0 | 0 | Palliative (P) | 2019-03-29 | 2019-04-11 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100548158 |
| 20212691 | 20079278 | 1.67 | 110 | Curative (C) | 2016-07-05 | 2016-07-05 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 100200212 |
| 20212693 | 20079279 | 1.78 | 85.6 | Palliative (P) | 2017-12-03 | 2017-12-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101719453 |
| 20212695 | 20079280 | 1.53 | 59 | null | 2016-05-11 | 2016-05-11 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101842993 |
| 20212696 | 20079281 | 1.82 | 72.8 | Neo-adjuvant (N) | 2019-06-22 | 2019-07-06 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100887405 |
| 20212697 | 20079282 | 1.68 | 101 | Curative (C) | 2016-11-13 | 2016-11-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100964704 |
| 20212699 | 20079283 | 0 | 0 | Curative (C) | 2021-12-24 | 2022-01-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100747322 |
| 20212700 | 20079284 | 1.66 | 61.2 | Curative (C) | 2018-06-04 | 2018-06-26 | CISPLATIN + FLUOROURACIL + RT | N | Y | CISPLATIN + FLUOROURACIL | 100537029 |